Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phaeosol
- Development stage
- Unknown
- Lead developer
- Microphyt
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Phaeosol is a branded microalgae-based nutritional ingredient developed by Microphyt, primarily standardized to contain the carotenoid fucoxanthin[2][4][6]. Its main purported benefits are *supporting maintenance of cognitive function in the elderly* and *preventing certain metabolic disorders*[2][4]. Phaeosol is produced using a patented industrial process involving *Phaeodactylum tricornutum* microalgae, resulting in extracts standardized for fucoxanthin content and delivered with coconut-derived medium-chain triglycerides for improved handling and stability[6]. It has received FDA New Dietary Ingredient (NDI) status, allowing commercialization for dietary supplement use in the United States[2][4]. Proprietary preclinical evidence supports its nutritional benefits for age-related cognitive decline, with the functional synergy attributed to unique bioactive molecules that enhance fucoxanthin's role in the body[4][6].
- Brand names
- Phaeosol
- Other names
- PhaeoSOL
02
Targets
Amyloid-beta aggregate (N-terminal epitope)
Beyond the preview
Go deeper on Phaeosol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phaeosol.